0NHS.L0NHS.LLSE
Loading
EBITDA Over TimeExpanding
Percentile Rank86
3Y CAGR-21.4%
5Y CAGR+16.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-21.4%/yr
vs +58.5%/yr prior
5Y CAGR
+16.5%/yr
Recent deceleration
Acceleration
-79.9pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$6.21B+47.5%
2024$4.21B-13.8%
2023$4.88B-61.8%
2022$12.78B+94.2%
2021$6.58B+127.6%
2020$2.89B-21.1%
2019$3.67B+81.2%
2018$2.02B+124.0%
2017$903.00M-22.0%
2016$1.16B-